In this targeted review, we summarize current knowledge on substance-use disorder (SUD)-
related cognitive deficits, the link between these deficits and clinical outcomes, and the …

Understanding the cognitive sequela of repeated cocaine use is a growing area of research
and is crucial to the development of cognitive models of addiction. We systematically …

Importance Substantial shifts in perception and policy regarding cannabis have recently
occurred, with use of cannabis increasing while its perceived harm decreases. One possible …

Hallucinogen persisting perception disorder (HPPD) is a drug-induced condition associated
with inaccurate visual representations. Since the underlying mechanism (s) are largely …

3, 4-Methylenedioxymethamphetamine (MDMA) is a synthetic amphetamine derivative with
notable psychoactive properties and emerging therapeutic potential, particularly for treating …

Any type of behavioral change is an effortful process. Thus, the process of behavioral
therapy, where clients seek to change maladaptive behavioral patterns, requires high‐level …

Mephedrone and MDMA are both constituents of party drugs, with mephedrone being
relatively new compared to MDMA. This review compares current knowledge regarding the …

The adverse effects of cannabis use on executive functions are still controversial, fostering
the need for novel biomarkers able to unveil individual differences in the cognitive impact of …

The synthetic psychostimulant MDMA (±3, 4-methylenedioxymethamphetamine, ecstasy)
acts as an indirect serotonin, dopamine, and norepinephrine agonist and as a mechanism …

Clinical outcome following 3, 4-methylenedioxymethamphetamine (MDMA) intake ranges
from mild entactogenic effects to a life-threatening intoxication. Despite ongoing research …